Canada became the first country in the world that has authorized the use of a plant-based COVID-19 vaccine. The two-dose vaccine of Medicago Inc. (a biopharma company owned by Mitsubishi Chemical and Philip Morris), can be given to adults who are aged between 18 to 64, but little data is available on the shots received by people aged 65 and above.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
The decision to authorize the vaccine was based on a study conducted on 24,000 adults that showed the efficacy rate of the vaccine is 71% at preventing COVID-19 – although the tests were conducted before the omicron variant emerged. Covifenz is the name given to this vaccine. Canada agreed to buy 20 million doses of this plant-based vaccine, with an option to purchase 56 million additional doses.
Important takeaways for all competitive exams:
India maintained its momentum at the Asian Games 2026 in Aichi-Nagoya, Japan, on Day 2…
Goalkeeper Savita Punia of India has broken Vandana Katariya's record to become the most capped…
Gwalior is set to emerge as a significant telecom manufacturing center with the upcoming development…
Minister of Home Affairs and Minister of Cooperation Amit Shah is all set to inaugurate…
Chandni Chowk’s historic Town Hall complex is gearing up for a new beginning as the…
Smriti Mandhana scripted another history in the international cricket again as she became the leading…